| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000033076 |
| Receipt No. | R000037713 |
| Scientific Title | The relationship between the time course of peritoneal function and adipocytokine |
| Date of disclosure of the study information | 2018/06/21 |
| Last modified on | 2020/07/09 (Ver. 3) |
| Basic information | ||
| Public title | The relationship between the time course of peritoneal function and adipocytokine | |
| Acronym | The relationship between the time course of peritoneal function and adipocytokine | |
| Scientific Title | The relationship between the time course of peritoneal function and adipocytokine | |
| Scientific Title:Acronym | The relationship between the time course of peritoneal function and adipocytokine | |
| Region |
|
|
| Condition | ||
| Condition | Chronic Kidney Disease Stage G5D | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We measure the serum adipocytokines of PD patients and investigate the correlation between serum LDL value and change in peritoneal function by Peritoneal Equilibration Test (PET). We also analyze the correlation between various parameters at the time of PD induction. Also, we clarify whether these adipocytokines are predictors of PD duration. Furthermore, these adipocytokines predict maintenance of peritoneal function and clarify whether it can be an indicator of appropriate PD treatment. |
| Basic objectives2 | Others |
| Basic objectives -Others | To investigate the relationship between peritoneal function and adipocytokine. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Correlation with adiponectin, leptin and apelin levels and rate of change of D / P ratio and D / D0 ratio over 6 months. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Peritoneal Dialysis Patients | |||
| Key exclusion criteria | Combination therapy with hemodialysis and peritoneal dialysis | |||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nippon Medical School | ||||||
| Division name | Department of Nephrology | ||||||
| Zip code | 113-8603 | ||||||
| Address | 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603 JAPAN | ||||||
| TEL | 03-3822-2131 | ||||||
| y-sakai@nms.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nippon Medical School | ||||||
| Division name | Department of Nephrology | ||||||
| Zip code | 113-8603 | ||||||
| Address | 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603 JAPAN | ||||||
| TEL | 03-3822-2131 | ||||||
| Homepage URL | |||||||
| y-sakai@nms.ac.jp | |||||||
| Sponsor | |
| Institute | Nippon Medical School |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nippon Medical School |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethics Committee of Noppon Medical School Hospital |
| Address | 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603 JAPAN |
| Tel | 03-3822-2131 |
| nms_fuzokurinri@nms.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | none |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037713 |